Trial Profile
Safety and Efficacy of BOTOX (Botulinum Toxin Type A) in Korea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines; Hyperhidrosis; Muscle spasticity
- Focus Adverse reactions; Therapeutic Use
- Sponsors Allergan
- 31 Jan 2014 New trial record